189 related articles for article (PubMed ID: 33827442)
1. Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States.
Sheikh-Taha M; Asmar M
BMC Geriatr; 2021 Apr; 21(1):233. PubMed ID: 33827442
[TBL] [Abstract][Full Text] [Related]
2. Potentially inappropriate home medications among older patients with cardiovascular disease admitted to a cardiology service in USA.
Sheikh-Taha M; Dimassi H
BMC Cardiovasc Disord; 2017 Jul; 17(1):189. PubMed ID: 28716041
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of drug-drug interactions in older people before and after hospital admission: analysis from the OPERAM trial.
Zerah L; Henrard S; Wilting I; O'Mahony D; Rodondi N; Dalleur O; Dalton K; Knol W; Haschke M; Spinewine A
BMC Geriatr; 2021 Oct; 21(1):571. PubMed ID: 34663238
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Factors Associated with Potential Drug-Drug Interactions in Older Community-Dwelling Adults: A Prospective Cohort Study.
Hughes JE; Russo V; Walsh C; Menditto E; Bennett K; Cahir C
Drugs Aging; 2021 Nov; 38(11):1025-1037. PubMed ID: 34632551
[TBL] [Abstract][Full Text] [Related]
6. Rationale, design, and methodology of the EPIC (Epidemiology of Polypharmacy and Potential Drug-Drug Interactions in Elderly Cardiac Outpatients) study.
Özlek E; Çekiç EG; Özlek B; Çil C; Çelik O; Doğan V; Başaran Ö; Tanık VO; Özdemir Hİ; Çelik Y; Kaçmaz C; Şimşek Z; Güneş HM; Şafak Ö; Özkan B; Tasar O; Önal Ç; Bekar L; Biteker M
Turk Kardiyol Dern Ars; 2019 Jul; 47(5):391-398. PubMed ID: 31311898
[TBL] [Abstract][Full Text] [Related]
7. Real-world prevalence of potential drug-drug interactions involving oral antineoplastic agents: a population-based study.
Kim SH; Suh Y; Ah YM; Jun K; Lee JY
Support Care Cancer; 2020 Aug; 28(8):3617-3626. PubMed ID: 31802250
[TBL] [Abstract][Full Text] [Related]
8. Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study.
Hosia-Randell HM; Muurinen SM; Pitkälä KH
Drugs Aging; 2008; 25(8):683-92. PubMed ID: 18665660
[TBL] [Abstract][Full Text] [Related]
9. Drug-drug interaction potential in men treated with enzalutamide: Mind the gap.
Benoist GE; van Oort IM; Smeenk S; Javad A; Somford DM; Burger DM; Mehra N; van Erp NP
Br J Clin Pharmacol; 2018 Jan; 84(1):122-129. PubMed ID: 28881501
[TBL] [Abstract][Full Text] [Related]
10. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study.
Lin CF; Wang CY; Bai CH
Drugs Aging; 2011 Mar; 28(3):219-25. PubMed ID: 21250763
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of potential drug-drug interactions in adults with intellectual disability.
McMahon M; Hatton C; Bowring DL; Hardy C; Preston NJ
J Intellect Disabil Res; 2021 Oct; 65(10):930-940. PubMed ID: 33988262
[TBL] [Abstract][Full Text] [Related]
12. Potential drug-drug interactions and polypharmacy in institutionalized elderly patients in a public hospital in Brazil.
Castilho ECD; Reis AMM; Borges TL; Siqueira LDC; Miasso AI
J Psychiatr Ment Health Nurs; 2018 Feb; 25(1):3-13. PubMed ID: 28892271
[TBL] [Abstract][Full Text] [Related]
13. Potential drug-drug interactions in drug therapy for older adults with chronic coronary syndrome at hospital discharge: A real-world study.
Zhao M; Liu CF; Feng YF; Chen H
Front Pharmacol; 2022; 13():946415. PubMed ID: 36091832
[No Abstract] [Full Text] [Related]
14. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management.
Sokol KC; Knudsen JF; Li MM
J Clin Pharm Ther; 2007 Apr; 32(2):169-75. PubMed ID: 17381667
[TBL] [Abstract][Full Text] [Related]
15. Use of over the counter products in older cardiovascular patients admitted to a tertiary care center in USA.
Sheikh-Taha M; Dimassi H
BMC Geriatr; 2018 Dec; 18(1):301. PubMed ID: 30514238
[TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of major drug-drug interactions in older adults with cancer and the role of clinical decision support software.
Nightingale G; Pizzi LT; Barlow A; Barlow B; Jacisin T; McGuire M; Swartz K; Chapman A
J Geriatr Oncol; 2018 Sep; 9(5):526-533. PubMed ID: 29510896
[TBL] [Abstract][Full Text] [Related]
18. Risk of Polypharmacy and Its Outcome in Terms of Drug Interaction in an Elderly Population: A Retrospective Cross-Sectional Study.
Alhumaidi RM; Bamagous GA; Alsanosi SM; Alqashqari HS; Qadhi RS; Alhindi YZ; Ayoub N; Falemban AH
J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373654
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and pattern of potential drug-drug interactions among chronic kidney disease patients in south-western Nigeria.
Olumuyiwa JF; Akinwumi AA; Ademola OA; Oluwole BA; Ibiene EO
Niger Postgrad Med J; 2017; 24(2):88-92. PubMed ID: 28762362
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital.
Ramasubbu SK; Mahato SK; Agnihotri A; Pasricha RK; Nath UK; Das B
Cancer Treat Res Commun; 2021; 26():100277. PubMed ID: 33348276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
